Keyphrases
Effectors Interaction
59%
Protein Prenylation
59%
Macrophage Proliferation
59%
Lesional Macrophage
59%
Proteasomal Degradation
59%
TRIP12
59%
Small Rho GTPases
59%
Rab25
59%
Protein Prenyltransferases
59%
CaaX Protein
59%
USP9X
59%
Deubiquitinase
59%
Erosive Arthritis
59%
Cell Energy Metabolism
59%
Reverse Cholesterol Transport
59%
Platinum Drugs
59%
3-bromopyruvate
59%
Chemopotentiator
59%
Metabolism Inhibitors
59%
Inhibitor-2
59%
2-Deoxy-d-glucose (2-DG)
59%
Anti-PD-1 Therapy
59%
Etomoxir
59%
Degradation Assessment
59%
Polycaprolactone Scaffold
59%
Independent Functions
59%
Exosomal
59%
Potential Biomarkers
59%
Immuno
59%
Tumor Response
59%
Non-small Cell Lung Cancer Patients
59%
Oncologic
59%
Nectin-4
59%
Programmed Death-ligand 1 (PD-L1)
52%
Prenylation
40%
Apolipoprotein E
40%
GGTase-I
40%
Exosomal PD-L1
37%
DYRK2
35%
Geranylgeranylation
35%
Genotoxic Drugs
35%
NSCLC Patients
29%
Farnesyltransferase
25%
Non-genotoxic
23%
Cholesterol Efflux
22%
ULBP3
22%
Immune Checkpoint Inhibitor Therapy
22%
P53 Activity
19%
Rac1-GTP
19%
Trp53
19%
Immunology and Microbiology
Arthritis
100%
Protein Prenylation
59%
Macrophage
59%
Intravenous Immunoglobulin
59%
Cholesterol Transport
59%
Programmed Death-Ligand 1
59%
Cell Energy
59%
Mouse
59%
Cytokine
59%
Prenylation
40%
Immunity
32%
Aerobic Glycolysis
29%
Low Drug Dose
29%
Antiproliferative Activity
29%
Protein Family
29%
Downregulation
21%
Bone Marrow Transplantation
20%
Multigene Family
19%
Rho Factor
19%
Upregulation
16%
Sialic Acid Binding Immunoglobulin Like Lectin
16%
Cell Membrane
14%
Inflammatory Cell
14%
Inflammatory Arthritis
14%
Inflammatory Disorder
14%
Proinflammatory Cytokine
14%
Exosome
10%
Lentivirus
7%
Lipid Level
7%
Scavenger Receptor
7%
Lipid Blood Level
7%
Drug Targeting
5%
Effector Cell
5%
Breed
5%
Drosophila Strain
5%
Enteroendocrine Cell
5%
Intestinal Stem Cell
5%
Immunology
5%
Overall Survival
5%
CD81
5%
Cadherin
5%
Chemokine
5%
CD63
5%
Nectin 2
5%
CD28
5%
NT5E
5%
CD80
5%
